Search company, investor...

ErlaCos

erlacos.com

Stage

Series A | Alive

About ErlaCos

Developer of cosmetic products. The company has developed products for the treatment of acne and cellulite.

Headquarters Location

Henkestraße 91

Erlangen, 92051,

Germany

49 91 31 40 00 91 7

Missing: ErlaCos's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ErlaCos's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

ErlaCos Patents

ErlaCos has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/12/2008

9/4/2012

Aromatase inhibitors, Hormonal antineoplastic drugs, Transcription factors, Antiandrogens, G protein coupled receptors

Grant

Application Date

11/12/2008

Grant Date

9/4/2012

Title

Related Topics

Aromatase inhibitors, Hormonal antineoplastic drugs, Transcription factors, Antiandrogens, G protein coupled receptors

Status

Grant

ErlaCos Frequently Asked Questions (FAQ)

  • Where is ErlaCos's headquarters?

    ErlaCos's headquarters is located at Henkestraße 91, Erlangen.

  • What is ErlaCos's latest funding round?

    ErlaCos's latest funding round is Series A.

  • Who are the investors of ErlaCos?

    Investors of ErlaCos include S-REFIT Regionaler Finanzierungsfonds fur Innovationen und Technologieunternehmen and medTECH Capital Fonds.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.